Updated
The most significant concentration Teladoc Health discloses is limited number of third-party suppliers, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Teladoc Health’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
“10-K Item 1A: 'our dependence on a limited number of third-party suppliers for timely access to materials, and the risk of supply chain disruptions, imposition or expansion of tariffs or further cost inflation'”
“10-K Item 1A: 'our top five Clients by revenue accounted for 19% and 18% of our total revenue, respectively, and 31% of our Integrated Care segment revenue for both years ended December 31, 2025 and 2024'”
Teladoc Health's disclosed concentration risks are relatively contained. On the supply side, the company notes dependence on a limited number of third-party suppliers for timely access to materials, layered with risk from supply chain disruptions and tariff or cost-inflation pressures — a dependency-type exposure without a specific disclosed percentage, but one that ties operational continuity to a small supplier base. On the customer side, the top five Clients by revenue accounted for 19% and 18% of total revenue in the two years shown, respectively, and 31% of Integrated Care segment revenue in both years. This is a disclosed low share at the total-revenue level, meaning the broader business is not heavily dependent on a handful of clients, though the concentration is notably higher within the Integrated Care segment specifically. Taken together, these exposures suggest Teladoc's overall revenue base is fairly diversified across customers, with the more idiosyncratic risk sitting in the Integrated Care segment's client concentration and in the supplier dependency for materials. Neither rises to a level that would dominate the investment thesis on its own, but the Integrated Care segment's client mix is the one area worth monitoring most closely for a counterparty-specific shock.
For the engine’s reasoning on TDOC’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| BTSG | BrightSpring Health Services, I | 0 | 2 | 0 | 2 |
| EVH | Evolent Health, Inc | 0 | 1 | 3 | 4 |
| CTEV | Claritev Corporation | 0 | 1 | 1 | 2 |
| DOCS | Doximity, Inc. | 0 | 1 | 1 | 2 |
| TDOC● | Teladoc Health, Inc. | 0 | 1 | 1 | 2 |
| CERT | Certara, Inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.